Navigation Links
AMPLICOR HIV-1 Monitor Test, v1.5

ProductsAMPLICOR HIV-1 Monitor Test, v1.5
Company Roche Diagnostics
Item AMPLICOR HIV-1 Monitor Test, v1.5
Features 
  • High levels of sensitivity for an accurate measurement of viral suppression in patients on anti-retroviral therapy
  • 100% specificity
  • A domain of linearity from 50 to 750,000 copies/mL1
  • Proven performance in major pharmaceutical studies
  • The only FDA-approved test which can measure HIV-1 RNA down to 50 copies/mL
  • Quantification of HIV-1 Group M subtypes A-G
Description The AMPLICOR HIV-1 MONITOR Test, v1.5, an FDA-approved HIV-1 RNA assay, is utilized for HIV-1 viral load testing, has been used in the regulatory approval for HIV-1 therapies, and is now found in eight out of 10 clinical laboratories worldwide.

The AMPLICOR HIV-1 MONITOR Test, v1.5 is an in vitro nucleic acid amplification test for the quantification of Human Immunodeficiency Virus Type 1 (HIV-1) RNA in human plasma. The test can be used to assess patient prognosis by measuring the baseline HIV-1 RNA level and to monitor the effects of anti-retroviral therapy by measuring changes in plasma HIV-1 RNA levels during the course of anti-retroviral treatment.

The Gold Standard in Viral Load Assessment

The AMPLICOR HIV-1 MONITOR Test was the first commercial FDA-approved test to quantify the amount of HIV-1 RNA. This test has been used for FDA approval of most of the currently approved anti-retroviral drugs. With a limited number of treatment regimens available to HIV-1 patients, the accurate monitoring of viral load levels is essential to establish and monitor the effectiveness of therapeutic regimens, assess the potential of drug resistance and identify treatment failure.

Info Roche DiagnosticsCall Roche Diagnostics to buy products (US and Canada only; other locations use number below) USACanada1-866-415-6694

Customer Service: 1-800-428-5074
Web site: http://www.roche-diagnostics.com

Related medicine products :

1. OraSure HIV-1 Oral Specimen Collection Device
2. OraQuick ADVANCE Rapid HIV-1/2 Antibody Test
3. Reveal Rapid HIV-1 Antibody Test
4. Vironostika HIV-1 Plus O Microelisa System
5. Genetic Systems HIV-1/HIV-2 Peptide EIA
6. ViroSeq HIV-1 Genotyping System
7. Procleix HIV-1/HCV Assay
8. NucliSens HIV-1 QT
9. OraSure HIV-1 Western Blo
10. Genetic Systems HIV-1 Western Blot
11. Cambridge Biotech HIV-1 (Western Blot)
... Access immunoassay system is ... benchtop analyzer that performs ... with panels that include ... infectious disease, blood virus, ...
...
...
...
Medicine Products:
(Date:5/25/2016)... ... May 25, 2016 , ... New studies published today ... workers across 15 states. The outcomes examined in these studies include recovery of ... and satisfaction with medical care. , “The goal of the studies is to ...
(Date:5/25/2016)... ... May 25, 2016 , ... Cheryl Bowker of Bowker Insurance Group has ... McKenna Good Hands Legacy Award. McKenna ran one of Allstate’s most successful agencies for ... all those who knew him. The award named for him is not given every ...
(Date:5/25/2016)... ... May 25, 2016 , ... Casa Velas, an adults-only ... of precious stones to complement its new wellness suites . The two 1,350 ... feature a plethora of special services and insuite amenities, from a custom soap selection ...
(Date:5/25/2016)... PALM BEACH COUNTY, FLA (PRWEB) , ... May 25, 2016 , ... ... Florida the latest technology to help turn back the hands of time of female ... with female aging and childbirth. Women with symptoms such as leakage, laxity, itchiness ...
(Date:5/25/2016)... ... May 25, 2016 , ... First Choice Emergency Room , the largest ... Nguyen, as the Medical Director of its new DeSoto facility. , “We are ... DeSoto location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... NEW YORK , May 23, 2016 /PRNewswire/ ... Mass Spectrometry Market Size, Share, Development, Growth and ... Platform (Hybrid, Single and Other), by Application (Drug ... Others), by End Users (Pharmaceuticals, Life Science and ... Published by P&S Market Research, the global ...
(Date:5/23/2016)... DHABI , UAE, May 23, 2016 ... the importance of Precision Medicine and the role ...     The First International Conference ... under the distinguished patronage and presence of Sheikh Nahyan ... The conference focused in Precision Medicine, which helps provide personalized ...
(Date:5/22/2016)... , May 23, 2016 ... develop its anti-fibrotic and anti-inflammatory compound DS102 in ... as in non-alcoholic steatohepatitis (NASH) patients. ... significantly sequestered in lung tissue and has bronchodilatory, ... after oral administration. The Company will publish further ...
Breaking Medicine Technology: